Advertisement

Expanding the Spectrum of Methylmalonic Acid-Induced Pallidal Stroke: First Reported Case of Metabolic Globus Pallidus Stroke in Transcobalamin II Deficiency

  • Lance Harrington Rodan
  • Navin Mishra
  • Ivanna Yau
  • Andrea Andrade
  • Komudi Siriwardena
  • Ingrid Tein
Case Report
Part of the JIMD Reports book series (JIMD, volume 11)

Abstract

A 10-year-old boy with transcobalamin II (TCII) deficiency on oral cyanocobalamin therapy presented with acute right hemiparesis and sensory axonal neuropathy in the context of an intercurrent viral illness. MRI demonstrated unilateral globus pallidus stroke with normal MRA. Echocardiogram was normal. Methylmalonic acid in serum was mildly elevated at 10.29 μmol/L (normal < 0.37 μmol/L), which was an 18-fold increase from his previous baseline. The patient was switched to IM cyanocobalamin and serum methylmalonic acid levels normalized over 6 months to 0.01 μmol/L. After 4 months of IM cyanocobalamin therapy, the neuropathy had resolved. Repeat MRI 4 months after the sentinel stroke demonstrated a chronic-appearing contralateral globus pallidus stroke of uncertain timing.

Conclusions: We are describing the first case of metabolic stroke and peripheral neuropathy in TCII deficiency. The neuropathy was responsive to parenteral hydroxycobalamin. Unilateral globus pallidus stroke in the appropriate clinical context should not exclude a metabolic etiology as it may herald contralateral involvement and may provide an opportunity for early recognition and treatment. IM hydroxycobalamin should be strongly considered in all patients with TCII, particularly when they reach later childhood. This case highlights the selective vulnerability of the globus pallidus to increased levels of methylmalonic acid of various causes, which is important for both diagnosis and ultimately understanding the mechanisms of neurological injury in this group of conditions. Metabolic stroke may occur with lower levels of methylmalonic acid than previously reported in the context of an intercurrent bioenergetic stressor.

Keywords

Globus Pallidus Nerve Conduction Study Methylmalonic Acid Selective Vulnerability Superficial Peroneal Nerve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Banerjee R, Ragsdale SW (2003) The many faces of vitamin B12: catalysis by cobalamin-dependent enzymes. Annu Rev Biochem 72:209–247PubMedCrossRefGoogle Scholar
  2. Begley JA, Colligan PD, Chu RC (1994) Synthesis and secretion of transcobalamin II by cultured astrocytes derived from human brain tissue. J Neurol Sci 122:57–60PubMedCrossRefGoogle Scholar
  3. Dutra JC, Dutra-Filho CS, Cardozo SE et al (1993) Inhibition of succinate dehydrogenase and beta-hydroxybutyrate dehydrogenase activities by methylmalonate in brain and liver of developing rats. J Inherit Metab Dis 16:147–153PubMedCrossRefGoogle Scholar
  4. Frattini D, Fusco C, Ucchino V, Tavazzi B, Della Giustina E (2010) Early onset methylmalonic aciduria and homocysteinuria cblC type with demyelinating neuropathy. Pediatr Neurol 43:135–138PubMedCrossRefGoogle Scholar
  5. Gimpert E, Jakob M, Hitzig WH (1975) Vitamin B12 transport in blood in congenital deficiency of transcobalamin II. Blood 45:71–82PubMedGoogle Scholar
  6. Heidenreich R, Natowicz M, Hainline BE, Kelley RI, Hillman RE et al (1988) Acute extrapyramidal syndrome in methylmalonic academia: “metabolic stroke” involving the globus pallidus. J Pediatr 113(6):1022–1027PubMedCrossRefGoogle Scholar
  7. Kaikov Y, Wadsworth LD, Hall CA, Rogers PC (1991) Transcobalamin II deficiency: case report and review of the literature. Eur J Pediatr 150:841–843PubMedCrossRefGoogle Scholar
  8. Ludolph AC, Ullrich K, Bick U, Fahrendorf G, Przyrembel H (1991) Functional and morphological deficits in late-treated patients with homocysteinuria: a clinical, electrophysiologic, and MRI studies. Acta Neurol Scand 83:161–165PubMedCrossRefGoogle Scholar
  9. Nishimura M, Yoshino K, Tomita Y, Takashima S, Tanaka J et al (1985) Central and peripheral nervous system pathology of homocysteinuria due to 5,10 –methylene tetrahydrofolate reductase deficiency. Pediatr Neurol 1(6):375–378PubMedCrossRefGoogle Scholar
  10. Okun JG, Horster F, Farkas LM, Feyh P, Hinz A, Sauer S et al (2002) Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and tricarboxylic acid cycle, and synergistically acting excitotoxicity. J Biol Chem 277:14674–14680PubMedGoogle Scholar
  11. Quadros EV (2009) Advances in the understanding of cobalamin assimilation and metabolism. Brit J Hematol 148:195–204CrossRefGoogle Scholar
  12. Regec A, Quadros EV, Platica O, Rothenberg SP (1995) The cloning and characterization of the human transcobalamin II gene. Blood 85:2711–2719PubMedGoogle Scholar
  13. Sakly G, Hellara O, Trabelsi A, Dogui M (2005) Reversible peripheral neuropathy induced by B12 deficiency. Neurophysiol Clin 35(5–6):149–153PubMedCrossRefGoogle Scholar
  14. Schiff M, Ogier de Baulny H, Bard G, Barlogis V, Hamil C, Moat SJ et al (2010) Should transcobalamin deficiency be treated aggressively. J Inherit Metab Dis 33:223–229PubMedCrossRefGoogle Scholar
  15. Sharrief AZ, Raffel J, Zee DS (2012) Vitamin B12 deficiency with bilateral globus pallidus abnormalities. Arch Neurol 69(6):769–772PubMedCrossRefGoogle Scholar
  16. Takahashi-Iñiguez T, Garcia-Hernandez E, Arreguin-Espinosa R, Flores ME (2012) Role of vitamin B12 on methylmalonyl-CoA mutase activity. J Zhejiang Univ-Sci B (Biomed & Biotechnol) 13(6):423–437CrossRefGoogle Scholar
  17. Trinh BC, Melhem ER, Barker PB (2001) Multi-slice proton MR spectroscopy and diffusion weighted imaging in methylmalonic academia: report of two cases and review of the literature. AJNR 22:831–833PubMedGoogle Scholar
  18. Watkins D, Rosenblatt DS (2011) Inborn errors of cobalamin absorption and metabolism. Am J Med Genet 157:33–44PubMedCrossRefGoogle Scholar

Copyright information

© SSIEM and Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Lance Harrington Rodan
    • 1
    • 4
  • Navin Mishra
    • 1
  • Ivanna Yau
    • 1
  • Andrea Andrade
    • 1
  • Komudi Siriwardena
    • 2
  • Ingrid Tein
    • 1
    • 3
  1. 1.Division of NeurologyUniversity of TorontoTorontoCanada
  2. 2.Division of Clinical and Metabolic Genetics, Dept. of Pediatrics, Hospital for Sick ChildrenUniversity of TorontoTorontoCanada
  3. 3.Dept. of Laboratory Medicine and PathobiologyUniversity of TorontoTorontoCanada
  4. 4.Division of NeurologyHospital for Sick ChildrenTorontoCanada

Personalised recommendations